You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Dara-KRd

Showing 1 - 25 of 47
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma, Primary Plasma Cell Leukemia, Extramedullary Multiple Myeloma Trial in Wuhan (Daratumumab, Carfilzomib,

Recruiting
  • Multiple Myeloma
  • +2 more
  • Wuhan, Hubei, China
    Institute of Hematology, Union Hospital, Tongji Medical College,
Nov 18, 2023

Multiple Myeloma Trial in France (Isatuximab, ASCT)

Recruiting
  • Multiple Myeloma
  • AMIENS Cedex 1, France
  • +67 more
Mar 28, 2022

Multiple Myeloma Trial in United States (bb2121, Fludarabine, Cyclophosphamide)

Active, not recruiting
  • Multiple Myeloma
  • bb2121
  • +3 more
  • Scottsdale, Arizona
  • +19 more
Jul 7, 2022

Kyprolis® in Combination With Revlimid® and Dexamethasone or

Recruiting
  • Multiple Myeloma in Relapse
  • Frankfurt, Germany
    Centrum für Hämatologie und Onkologie Bethanien
Jun 2, 2022

Multiple Myeloma Trial in Sweden, United States (Bortezomib, Dexamethasone, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Miami, Florida
  • +8 more
Nov 23, 2021

Multiple Myeloma Trial in United States (KRdD followed by auto-HCT, KRdD only)

Active, not recruiting
  • Multiple Myeloma
  • KRdD followed by auto-HCT
  • KRdD only
  • Birmingham, Alabama
  • +3 more
Mar 26, 2022

Multiple Myeloma Trial in Miami (Teclistamab, Talquetamab, Daratumumab SC)

Not yet recruiting
  • Multiple Myeloma
  • Miami, Florida
    University of Miami
Oct 20, 2023

Multiple Myeloma, Renal Failure Trial in Augusta (Daratumumab-hyaluronidase in Combination with Bortezomib, Cyclophosphamide,

Not yet recruiting
  • Multiple Myeloma
  • Renal Failure
  • Daratumumab-hyaluronidase in Combination with Bortezomib, Cyclophosphamide, and Dexamethasone
  • Augusta, Georgia
    Georgia Cancer Center-Augusta University
Nov 16, 2023

Multiple Myeloma Trial in Worldwide (Carfilzomib Lenalidomide Dexamethasone, Isatuximab Carfilzomib Lenalidomide Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Carfilzomib Lenalidomide Dexamethasone
  • Isatuximab Carfilzomib Lenalidomide Dexamethasone
  • Ostrava, Czechia
  • +6 more
Jul 26, 2022

High-Risk de Novo Multiple Myeloma Trial in Spain (Daratumumab, Bortezomib, Lenalidomide)

Not yet recruiting
  • High-Risk de Novo Multiple Myeloma
  • Badalona, Spain
  • +9 more
Apr 27, 2023

Multiple Myeloma Trial in Worldwide (Dara SC, Dara IV)

Active, not recruiting
Has Results
  • Multiple Myeloma
  • Dara SC
  • Dara IV
  • Boston, Massachusetts
  • +145 more
Jan 17, 2023

Relapsed or Refractory Multiple Myeloma Trial in Worldwide (Carfilzomib, Lenalidomide, Dexamethasone)

Active, not recruiting
  • Relapsed or Refractory Multiple Myeloma
  • Fountain Valley, California
  • +107 more
Dec 7, 2022

Long-term KRd in Relapsed and/or Refractory Multiple Myeloma

Not yet recruiting
  • Multiple Myeloma in Relapse
  • Multiple Myeloma, Refractory
  • (no location specified)
Aug 8, 2022

Multiple Myeloma Trial in Worldwide (Daratumumab, Pomalidomide, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • Birmingham, Alabama
  • +198 more
Jan 17, 2023

Relapsed or Refractory Multiple Myeloma Trial (Daratumumab, Pomalidomide)

Withdrawn
  • Relapsed or Refractory Multiple Myeloma
  • (no location specified)
Jan 26, 2023

AL Amyloidosis Trial (procedure, drug, other)

Not yet recruiting
  • AL Amyloidosis
  • Autologous Hematopoietic Stem Cell Transplantation
  • +15 more
  • (no location specified)
Aug 28, 2023

Maintenance With Bortezomib Plus Daratumumab After Induction

Recruiting
  • Multiple Myeloma
  • Non-eligible for Autologous Stem Cell Transplantation (ASCT)
  • Arganda Del Rey, Spain
  • +31 more
Sep 15, 2022

Multiple Myeloma Trial in Seoul (Lenalidomide maintenance)

Recruiting
  • Multiple Myeloma
  • Lenalidomide maintenance
  • Seoul, Korea, Republic of
    Samsung Medical Center
Aug 10, 2022

Multiple Myeloma Trial in Worldwide (Talquetamab, Teclistamab, Daratumumab)

Recruiting
  • Multiple Myeloma
  • Edmonton, Alberta, Canada
  • +12 more
Jan 27, 2023

Multiple Myeloma, New Diagnosis Tumor Trial in Italy (Carfilzomib, Lenalidomide, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • New Diagnosis Tumor
  • Alessandria, Italy
  • +41 more
Mar 24, 2022

Plasma Cell Leukemia Trial (Daratumumab)

Not yet recruiting
  • Plasma Cell Leukemia
  • (no location specified)
Sep 22, 2021

Multiple Myeloma Trial in Worldwide (Carfilzomib 20 mg/m^2, Carfilzomib 70 mg/m^2, Dexamethasone 40 mg)

Active, not recruiting
  • Multiple Myeloma
  • Carfilzomib 20 mg/m^2
  • +4 more
  • Gilbert, Arizona
  • +107 more
Dec 20, 2022

Multiple Myeloma Trial (Pembrolizumab)

Withdrawn
  • Multiple Myeloma
  • (no location specified)
Apr 20, 2022

Multiple Myeloma Trial in Torino (Velcade, Melphalan, Prednisone)

Recruiting
  • Multiple Myeloma
  • Torino, TO, Italy
    Dipartimento di Biotecnologie Molecolari e Scienze per la Salute
May 25, 2022

Multiple Myeloma Trial in Worldwide (Daratumumab Subcutaneous (SC) Administration, Recombinant Human Hyaluronidase [rHuPH20]) SC

Active, not recruiting
  • Multiple Myeloma
  • Daratumumab Subcutaneous (SC) Administration
  • Recombinant Human Hyaluronidase [rHuPH20]) SC Administration
  • Atlanta, Georgia
  • +11 more
Aug 11, 2022